Pharma PLI attracts over Rs 46,700 crore investments, but China still dominates API imports India’s pharmaceutical PLI scheme recorded ₹46,744 crore in investments by June 2026, driving ₹4.03 lakh crore in total sales despite… Updated: September 26, 2026 01:22 IST
Govt revives pharma logistics study; plans to map 10-year infra needs The Department of Pharmaceuticals issued a revised RfP to select a consultant to evaluate infrastructure gaps and map out a… September 24, 2026 18:59 IST
Noida airport, Dadri proposed among 10 new drug import points The Drugs Technical Advisory Board has recommended expanding Rule 43A by adding 10 new entry points, including Noida International Airport… September 18, 2026 18:24 IST
Taking science to market IISc’s deeptech startups turn advanced research into real-world solutions September 16, 2026 19:56 IST
GLP-1 market to grow four-fold to Rs 15,700 crore by FY32; Sun Pharma, Eris, Torrent among likely gainers The domestic GLP-1 market for obesity and diabetes drugs is set to nearly quadruple to Rs 15,700 crore by FY32,… September 10, 2026 18:53 IST
Tariffs may raise US drug prices; manufacturing shift not easy: Lupin global CFO The proposed 100-200% US tariffs on generic drugs could raise medicine prices or cause shortages, as drugmakers may struggle to… Updated: September 10, 2026 14:12 IST
Medical tourism startups await their funding cure Foreign patients surge, but low asset creation keeps investors cautious Updated: August 24, 2026 05:10 IST
Govt eyes up to 45% domestic value addition in medical devices under next PLI India’s domestic medical device manufacturing grew 43%, but DCGI and Department of Pharmaceuticals cite weak innovation and push for higher… August 21, 2026 19:29 IST
Pharma sector growth stays strong in FY27; margins to soften as costs escalate: Ind-Ra India Ratings expects domestic pharma growth of ~10% in FY27, though US market weakness and rising input/logistics costs may weigh… August 19, 2026 18:50 IST
Drugmakers shifting to non-US, non-generic markets to ward off margin squeeze Facing US price erosion and impending drug import tariffs, Indian pharma leaders like Sun Pharma, Lupin, and Dr Reddy’s are… Updated: August 17, 2026 05:30 IST
Pharma upgrade drive faces delays; just 18% units get incentives Slow disbursement under the government’s RPTUAS scheme highlights operational hurdles faced by MSME drugmakers as less than half achieve compliance… Updated: August 10, 2026 05:06 IST
After quick-commerce, now quick doctor within minutes Doc home visits in 20-60 minutes getting popular August 8, 2026 23:53 IST
Panel urges govt to explore return to cost-based pricing of essential medicines A parliamentary standing committee has recommended that the Indian government re-examine returning to a cost-based price fixation mechanism for essential… August 7, 2026 19:04 IST
Drug regulator overhauls export norms; tightens checks on unapproved medicines The Central Drugs Standard Control Organisation (CDSCO) has tightened India’s drug export NOC rules. July 30, 2026 19:50 IST
Medtech gets India boost as Siemens Healthineers scales high-tech manufacturing from Bengaluru Siemens Healthcare scales high-tech manufacturing from Bengaluru. Updated: July 30, 2026 08:51 IST
Explainer: How Qdenga can be a shot in the arm for dengue prevention The Central Drugs Standard Control Organisation (CDSCO) has approved Takeda’s Qdenga, making it India’s first licensed dengue vaccine for individuals… July 23, 2026 19:04 IST
US tariff threat keeps drugmakers on their toes Move may unravel given US consumers’ reliance on India’s low-cost generics, analysts feel July 22, 2026 22:08 IST
AI to strengthen maternal care, not replace clinical judgement Fernandez Foundation CEO says compassion remains healthcare’s defining strength amid transformation. Updated: July 19, 2026 18:11 IST
